Heidi Hagen

Companies

• Obsidian Therapeutics, Inc.Board member Aug 3, 2026 to now¹
• VericelBoard member Aug 27, 2013 to now²
• ZIOPHARM OncologyBoard member Jun 17, 2019 to Sep 3, 2021³
• ZIOPHARM OncologyChief executive officer Mar 8, 2021 to Mar 8, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VVericel VCEL35,050 shares⁵$1.4M at $40.34Apr 29, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 29, 2026Exercised options 3,200 shares of Vericel⁵
• Mar 23, 2026Sold 15,000 shares at $32.41 of Vericel⁶
• Mar 23, 2026Exercised options 15,000 shares at $2.76 of Vericel⁶
• Apr 30, 2025Exercised options 3,200 shares of Vericel⁷
• Mar 3, 2025Sold 9,000 shares at $49.53 of Vericel⁸
• Mar 3, 2025Exercised options 9,000 shares at $3.74 of Vericel⁸
• Oct 17, 2024Exercised options 6,000 shares at $3.74 of Vericel⁹
• Oct 17, 2024Exercised options 4,000 shares at $3.74 of Vericel⁹
• May 1, 2024Exercised options 3,200 shares of Vericel¹⁰
• Apr 27, 2023Exercised options 2,600 shares of Vericel¹¹
• Apr 27, 2022Exercised options 2,600 shares of Vericel¹²